Skip to content

Ayurvedic intervention in Menstrual Disorder

An Open Labelled Comparative Clinical Study To Evaluate The Efficacy Of Udumbara Phala Extract Nasya And Udumbara Phala Extract Nasya Along With Bolabaddha Rasa In The management Of Asrigdara W.S.R. To Dysfunctional Uterine Bleeding - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/066545
Enrollment
40
Registered
2024-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle Health Condition 2: N920- Excessive and frequent menstruation with regular cycle

Interventions

None listed

Sponsors

Parul Institute of Ayurved
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who were willing for the hospital trial Patients fulfilling the diagnostic criteria. Patients with complaint of excessive bleeding P/V. Patients diagnosed as DUB (without organic pathology) Both married and unmarried women

Exclusion criteria

Exclusion criteria: Patients not willing for trial Patients with systemic disorders interfering with the present study like HTN, DM Patients with IUCD and patients taking OCPs Patients with uterine and pelvic pathology (fibroid, adenomyosis), Benign and malignant growth in uterus Endometrial and Endocervical polyp Patient with Hb less than 7 gm% Threatened, spontaneous or incomplete abortion

Design outcomes

Primary

MeasureTime frame
Duration, amount, regularity of mensesTimepoint: 30th day, 60th day and 90th day

Secondary

MeasureTime frame
Also reduce symptoms like Angamarda, Daurbalya, Bhrama, Aruchi, Daha, TrushnaTimepoint: 30 th day, 60 th day and 90th day

Countries

India

Contacts

Public ContactDr Lumi Bhagat

Parul Institute of Ayurved

lumibhagat31@gmail.com8319352370

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026